Themis Medicare Limited has informed the Exchange regarding a press release dated November 10, 2023, titled " Themis Medicare Launches REMITHEM�� REMIFENTANIL Injection A Novel Narcotic Analgesic for use during induction of anesthesia, during immediate post-operative period and in monitored anesthesia care .".